Drug intelligence / Profile preview

ascorbic acid + alpha-tocopherol

Development stage
Unknown
Lead developer
University of Alabama at Birmingham
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

Ascorbic acid (Vitamin C) and alpha-tocopherol (Vitamin E) are being evaluated as a combination antioxidant therapy by the University of Alabama at Birmingham for the prevention of coagulopathy and nosocomial pneumonia in patients following severe trauma. Traumatic injury often leads to significant oxidative stress, which can trigger systemic inflammatory responses and organ dysfunction. Ascorbic acid acts as a potent water-soluble antioxidant that scavenges reactive oxygen species (ROS) in the cytosol and extracellular fluid, while alpha-tocopherol serves as a lipid-soluble antioxidant that protects cell membranes from lipid peroxidation. This synergistic combination is intended to mitigate oxidative damage and improve clinical outcomes in critically injured patients. A Phase 2 clinical trial (NCT00182728) was conducted to assess the efficacy of this regimen in reducing the incidence of organ failure and infectious complications in the intensive care unit setting.

Other names
Vitamin C + Vitamin EAntioxidant Vitamins

Beyond the preview

Go deeper on ascorbic acid + alpha-tocopherol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ascorbic acid + alpha-tocopherol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call